December 3, 2014 by Brad Perriello
Direct Flow Medical said today that it landed a $32 million funding round for its replacement heart valve technology and tapped a 25-year medical device veteran, Chris Richardson, to lead its commercialization program.
October 1, 2014 by Alex Soule
August 21, 2014 by Brad Perriello
Direct Flow Medical said today that it won CE Mark approval in the European Union for an additional size of its replacement heart valve, plus an EU OK for the use of the devices without contrast media.
Direct Flow Medical said the FDA granted an investigational device exemption for a U.S. pivotal trial for its transcatheter aortic valve implant.
California-based medtech company Direct Flow Medical landed $50 million in debt financing, planning on using the new funds to support commercialization of a new transcatheter aortic valve implantation system.